Which has preferable valuation and earnings, NEO or LYFT?

Lyft has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Lyft, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeoGenomics $727.33M 1.96 -$108.03M -$0.77 N/A Lyft $6.32B 0.84 $2.84B $6.85 2.05

Is NEO or LYFT more profitable?

Lyft has a net margin of 43.82% compared to NeoGenomics' net margin of -13.30%. Lyft's return on equity of -2.09% beat NeoGenomics' return on equity. Company Net Margins Return on Equity Return on Assets NeoGenomics -13.30% -2.80% -1.72% Lyft 43.82% -2.09% -0.54%

Does the media favor NEO or LYFT?

In the previous week, Lyft had 24 more articles in the media than NeoGenomics. MarketBeat recorded 25 mentions for Lyft and 1 mentions for NeoGenomics. Lyft's average media sentiment score of 0.45 beat NeoGenomics' score of 0.00 indicating that Lyft is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lyft 9 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral

Which has higher earnings and valuation, NEO or EQPT?

EquipmentShare.com has higher revenue and earnings than NeoGenomics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeoGenomics $727.33M 1.96 -$108.03M -$0.77 N/A EquipmentShare.com $4.38B 1.15 $40M N/A N/A

Does the media prefer NEO or EQPT?

In the previous week, NeoGenomics and NeoGenomics both had 1 articles in the media. EquipmentShare.com's average media sentiment score of 0.67 beat NeoGenomics' score of 0.00 indicating that EquipmentShare.com is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EquipmentShare.com 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, NEO or XMTR?

Xometry has lower revenue, but higher earnings than NeoGenomics. Xometry is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NeoGenomics $727.33M 1.96 -$108.03M -$0.77 N/A Xometry $686.63M 6.20 -$61.74M -$1.02 N/A

Is NEO or XMTR more profitable?

Xometry has a net margin of -7.01% compared to NeoGenomics' net margin of -13.30%. NeoGenomics' return on equity of -2.80% beat Xometry's return on equity. Company Net Margins Return on Equity Return on Assets NeoGenomics -13.30% -2.80% -1.72% Xometry -7.01% -4.37% -1.71%

Does the media prefer NEO or XMTR?

In the previous week, Xometry had 12 more articles in the media than NeoGenomics. MarketBeat recorded 13 mentions for Xometry and 1 mentions for NeoGenomics. Xometry's average media sentiment score of 0.60 beat NeoGenomics' score of 0.00 indicating that Xometry is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Xometry 4 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, WSC or NEO?

WillScot has higher revenue and earnings than NeoGenomics. WillScot is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio WillScot $2.28B 2.13 -$52.99M -$0.38 N/A NeoGenomics $727.33M 1.96 -$108.03M -$0.77 N/A

Is WSC or NEO more profitable?

WillScot has a net margin of -2.99% compared to NeoGenomics' net margin of -13.30%. WillScot's return on equity of 20.65% beat NeoGenomics' return on equity. Company Net Margins Return on Equity Return on Assets WillScot -2.99% 20.65% 3.31% NeoGenomics -13.30% -2.80% -1.72%

Does the media favor WSC or NEO?

In the previous week, WillScot had 1 more articles in the media than NeoGenomics. MarketBeat recorded 2 mentions for WillScot and 1 mentions for NeoGenomics. WillScot's average media sentiment score of 0.97 beat NeoGenomics' score of 0.00 indicating that WillScot is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment WillScot 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, HRI or NEO?

Herc has higher revenue and earnings than NeoGenomics. Herc is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Herc $4.38B 1.11 $1M -$0.27 N/A NeoGenomics $727.33M 1.96 -$108.03M -$0.77 N/A

Is HRI or NEO more profitable?

Herc has a net margin of -0.11% compared to NeoGenomics' net margin of -13.30%. Herc's return on equity of 10.72% beat NeoGenomics' return on equity. Company Net Margins Return on Equity Return on Assets Herc -0.11% 10.72% 1.49% NeoGenomics -13.30% -2.80% -1.72%

Does the media prefer HRI or NEO?

In the previous week, Herc had 3 more articles in the media than NeoGenomics. MarketBeat recorded 4 mentions for Herc and 1 mentions for NeoGenomics. Herc's average media sentiment score of 0.13 beat NeoGenomics' score of 0.00 indicating that Herc is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Herc 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

NeoGenomics (NEO) Competitors

$10.95 +0.05 (+0.46%)

Closing price 04:00 PM Eastern

Extended Trading

$11.19 +0.24 (+2.19%)

As of 07:05 PM Eastern

Compare

NEO vs. LYFT, EQPT, XMTR, WSC, and HRI

Should you buy NeoGenomics stock or one of its competitors? MarketBeat compares NeoGenomics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NeoGenomics include Lyft (LYFT), EquipmentShare.com (EQPT), Xometry (XMTR), WillScot (WSC), and Herc (HRI). These companies are all part of the "business services" industry.

How does NeoGenomics compare to Lyft?

NeoGenomics (NASDAQ:NEO) and Lyft (NASDAQ:LYFT) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

NeoGenomics presently has a consensus target price of $13.86, suggesting a potential upside of 26.55%. Lyft has a consensus target price of $18.83, suggesting a potential upside of 34.29%. Given Lyft's higher probable upside, analysts plainly believe Lyft is more favorable than NeoGenomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
Lyft	2 Sell rating(s)	23 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.18

In the previous week, Lyft had 24 more articles in the media than NeoGenomics. MarketBeat recorded 25 mentions for Lyft and 1 mentions for NeoGenomics. Lyft's average media sentiment score of 0.45 beat NeoGenomics' score of 0.00 indicating that Lyft is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lyft	9 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

Lyft has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Lyft, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$727.33M	1.96	-$108.03M	-$0.77	N/A
Lyft	$6.32B	0.84	$2.84B	$6.85	2.05

NeoGenomics has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market. Comparatively, Lyft has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market.

Lyft has a net margin of 43.82% compared to NeoGenomics' net margin of -13.30%. Lyft's return on equity of -2.09% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
Lyft	43.82%	-2.09%	-0.54%

98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 83.1% of Lyft shares are owned by institutional investors. 1.1% of NeoGenomics shares are owned by company insiders. Comparatively, 0.9% of Lyft shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Lyft beats NeoGenomics on 11 of the 15 factors compared between the two stocks.

How does NeoGenomics compare to EquipmentShare.com?

NeoGenomics (NASDAQ:NEO) and EquipmentShare.com (NASDAQ:EQPT) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

98.5% of NeoGenomics shares are owned by institutional investors. 1.1% of NeoGenomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

EquipmentShare.com has a net margin of 0.00% compared to NeoGenomics' net margin of -13.30%. EquipmentShare.com's return on equity of 0.00% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
EquipmentShare.com	N/A	N/A	N/A

EquipmentShare.com has higher revenue and earnings than NeoGenomics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$727.33M	1.96	-$108.03M	-$0.77	N/A
EquipmentShare.com	$4.38B	1.15	$40M	N/A	N/A

NeoGenomics presently has a consensus target price of $13.86, indicating a potential upside of 26.55%. EquipmentShare.com has a consensus target price of $40.25, indicating a potential upside of 101.55%. Given EquipmentShare.com's stronger consensus rating and higher probable upside, analysts clearly believe EquipmentShare.com is more favorable than NeoGenomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
EquipmentShare.com	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

In the previous week, NeoGenomics and NeoGenomics both had 1 articles in the media. EquipmentShare.com's average media sentiment score of 0.67 beat NeoGenomics' score of 0.00 indicating that EquipmentShare.com is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
EquipmentShare.com	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

EquipmentShare.com beats NeoGenomics on 8 of the 11 factors compared between the two stocks.

How does NeoGenomics compare to Xometry?

NeoGenomics (NASDAQ:NEO) and Xometry (NASDAQ:XMTR) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Xometry has a net margin of -7.01% compared to NeoGenomics' net margin of -13.30%. NeoGenomics' return on equity of -2.80% beat Xometry's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
Xometry	-7.01%	-4.37%	-1.71%

Xometry has lower revenue, but higher earnings than NeoGenomics. Xometry is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$727.33M	1.96	-$108.03M	-$0.77	N/A
Xometry	$686.63M	6.20	-$61.74M	-$1.02	N/A

In the previous week, Xometry had 12 more articles in the media than NeoGenomics. MarketBeat recorded 13 mentions for Xometry and 1 mentions for NeoGenomics. Xometry's average media sentiment score of 0.60 beat NeoGenomics' score of 0.00 indicating that Xometry is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Xometry	4 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.5% of NeoGenomics shares are held by institutional investors. Comparatively, 97.3% of Xometry shares are held by institutional investors. 1.1% of NeoGenomics shares are held by company insiders. Comparatively, 9.1% of Xometry shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

NeoGenomics has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market. Comparatively, Xometry has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

NeoGenomics currently has a consensus price target of $13.86, suggesting a potential upside of 26.55%. Xometry has a consensus price target of $76.00, suggesting a potential downside of 7.54%. Given NeoGenomics' higher possible upside, equities research analysts plainly believe NeoGenomics is more favorable than Xometry.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
Xometry	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Summary

Xometry beats NeoGenomics on 8 of the 15 factors compared between the two stocks.

How does NeoGenomics compare to WillScot?

WillScot (NASDAQ:WSC) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

WillScot has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market. Comparatively, NeoGenomics has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market.

95.8% of WillScot shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 3.1% of WillScot shares are held by insiders. Comparatively, 1.1% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

WillScot presently has a consensus price target of $25.88, suggesting a potential downside of 3.85%. NeoGenomics has a consensus price target of $13.86, suggesting a potential upside of 26.55%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts clearly believe NeoGenomics is more favorable than WillScot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WillScot	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

WillScot has a net margin of -2.99% compared to NeoGenomics' net margin of -13.30%. WillScot's return on equity of 20.65% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WillScot	-2.99%	20.65%	3.31%
NeoGenomics	-13.30%	-2.80%	-1.72%

WillScot has higher revenue and earnings than NeoGenomics. WillScot is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WillScot	$2.28B	2.13	-$52.99M	-$0.38	N/A
NeoGenomics	$727.33M	1.96	-$108.03M	-$0.77	N/A

In the previous week, WillScot had 1 more articles in the media than NeoGenomics. MarketBeat recorded 2 mentions for WillScot and 1 mentions for NeoGenomics. WillScot's average media sentiment score of 0.97 beat NeoGenomics' score of 0.00 indicating that WillScot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WillScot	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

WillScot beats NeoGenomics on 10 of the 16 factors compared between the two stocks.

How does NeoGenomics compare to Herc?

Herc (NYSE:HRI) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Herc presently has a consensus target price of $165.67, indicating a potential upside of 13.96%. NeoGenomics has a consensus target price of $13.86, indicating a potential upside of 26.55%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts plainly believe NeoGenomics is more favorable than Herc.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Herc	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

Herc has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, NeoGenomics has a beta of 1.82, meaning that its share price is 82% more volatile than the broader market.

93.1% of Herc shares are owned by institutional investors. Comparatively, 98.5% of NeoGenomics shares are owned by institutional investors. 2.2% of Herc shares are owned by insiders. Comparatively, 1.1% of NeoGenomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Herc has higher revenue and earnings than NeoGenomics. Herc is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Herc	$4.38B	1.11	$1M	-$0.27	N/A
NeoGenomics	$727.33M	1.96	-$108.03M	-$0.77	N/A

Herc has a net margin of -0.11% compared to NeoGenomics' net margin of -13.30%. Herc's return on equity of 10.72% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Herc	-0.11%	10.72%	1.49%
NeoGenomics	-13.30%	-2.80%	-1.72%

In the previous week, Herc had 3 more articles in the media than NeoGenomics. MarketBeat recorded 4 mentions for Herc and 1 mentions for NeoGenomics. Herc's average media sentiment score of 0.13 beat NeoGenomics' score of 0.00 indicating that Herc is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Herc	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Herc beats NeoGenomics on 10 of the 16 factors compared between the two stocks.

Get NeoGenomics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NEO vs. The Competition

Export

Metric	NeoGenomics	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.42B	$3.34B	$6.49B	$11.99B
Dividend Yield	N/A	2.30%	2.67%	5.57%
P/E Ratio	-14.22	10.38	20.24	21.95
Price / Sales	1.96	298.43	507.57	108.00
Price / Cash	32.53	51.45	26.99	37.25
Price / Book	1.69	8.04	10.28	6.78
Net Income	-$108.03M	$23.89M	$3.57B	$337.51M
7 Day Performance	4.89%	-5.97%	-1.43%	-2.72%
1 Month Performance	22.21%	2.78%	3.27%	1.87%
1 Year Performance	47.57%	36.26%	23.37%	26.61%

NeoGenomics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NEO NeoGenomics	2.7358 of 5 stars	$10.95 +0.5%	$13.86 +26.5%	+46.9%	$1.42B	$727.33M	N/A	2,500
LYFT Lyft	4.6219 of 5 stars	$14.86 +5.3%	$18.83 +26.7%	-12.1%	$5.36B	$6.52B	2.17	3,913
EQPT EquipmentShare.com	4.2249 of 5 stars	$19.84 -4.8%	$40.25 +102.9%	N/A	$5.26B	$4.38B	N/A	7,700
XMTR Xometry	2.2536 of 5 stars	$95.25 0.0%	$76.00 -20.2%	+119.5%	$4.94B	$686.63M	N/A	1,174
WSC WillScot	3.2614 of 5 stars	$25.18 -2.1%	$25.88 +2.8%	-7.1%	$4.65B	$2.27B	N/A	4,700	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NEO) was last updated on 6/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NeoGenomics (NEO) Competitors